1984. Ceftriaxone-Sulbactam-EDTA vs. Meropenem: Analysis of Failed Patients With Assessment of MIC Increases and Changes in Genotypic Profile in PLEA (a Phase 3, Randomized, Double-Blind Clinical Trial in Adults With Complicated Urinary Tract Infections or Acute Pyelonephritis)

BACKGROUND: Ceftriaxone–sulbactam–EDTA (CSE) is a novel combination being developed to treat serious infections caused by Gram-negative bacteria. In vitro molecular biology studies have shown that the addition of EDTA in the combination helps to prevent horizontal gene transfer during conjugation by...

全面介紹

Na minha lista:
書目詳細資料
發表在:Open Forum Infect Dis
Main Authors: Mir, Mohd Amin, Chaudhary, Saransh, Chaudhary, Manu, Pyasi, Anurag, Patil, N S, Girotra, Ruchi, Narang, Salil, Fatima, Nazish
格式: Artigo
語言:Inglês
出版: Oxford University Press 2018
主題:
Abstracts
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC6253802/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofy210.1640
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍